JP2024530954A5 - - Google Patents

Info

Publication number
JP2024530954A5
JP2024530954A5 JP2024508382A JP2024508382A JP2024530954A5 JP 2024530954 A5 JP2024530954 A5 JP 2024530954A5 JP 2024508382 A JP2024508382 A JP 2024508382A JP 2024508382 A JP2024508382 A JP 2024508382A JP 2024530954 A5 JP2024530954 A5 JP 2024530954A5
Authority
JP
Japan
Prior art keywords
antibody
injection
antigen
binding fragment
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024508382A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530954A (ja
Filing date
Publication date
Priority claimed from GBGB2115152.7A external-priority patent/GB202115152D0/en
Priority claimed from GBGB2204211.3A external-priority patent/GB202204211D0/en
Priority claimed from GBGB2204291.5A external-priority patent/GB202204291D0/en
Application filed filed Critical
Priority claimed from PCT/GB2022/052070 external-priority patent/WO2023017252A1/en
Publication of JP2024530954A publication Critical patent/JP2024530954A/ja
Publication of JP2024530954A5 publication Critical patent/JP2024530954A5/ja
Pending legal-status Critical Current

Links

JP2024508382A 2021-08-10 2022-08-09 アトピー性皮膚炎の処置 Pending JP2024530954A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB202111492 2021-08-10
GB2111492.1 2021-08-10
GB2115152.7 2021-10-21
GBGB2115152.7A GB202115152D0 (en) 2021-10-21 2021-10-21 Treatment of atopic dermatitis
GBGB2204211.3A GB202204211D0 (en) 2022-03-24 2022-03-24 Treatment of atopic dermatitis
GB2204211.3 2022-03-24
GBGB2204291.5A GB202204291D0 (en) 2022-03-25 2022-03-25 Treatment of atopic dermatitis
GB2204291.5 2022-03-25
PCT/GB2022/052070 WO2023017252A1 (en) 2021-08-10 2022-08-09 Treatment of atopic dermatitis

Publications (2)

Publication Number Publication Date
JP2024530954A JP2024530954A (ja) 2024-08-27
JP2024530954A5 true JP2024530954A5 (https=) 2025-08-19

Family

ID=82942548

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508382A Pending JP2024530954A (ja) 2021-08-10 2022-08-09 アトピー性皮膚炎の処置

Country Status (11)

Country Link
US (2) US20230235069A1 (https=)
EP (1) EP4384270A1 (https=)
JP (1) JP2024530954A (https=)
KR (1) KR20240043789A (https=)
AR (1) AR126749A1 (https=)
AU (1) AU2022326849A1 (https=)
CA (1) CA3228708A1 (https=)
IL (1) IL310701A (https=)
MX (1) MX2024001877A (https=)
TW (1) TW202330023A (https=)
WO (1) WO2023017252A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024261177A1 (en) * 2023-06-20 2024-12-26 Kymab Limited Dosing and treatment of immune-mediated diseases and biomarkers associated with immune-mediated diseases
WO2025090570A1 (en) * 2023-10-23 2025-05-01 Abcellera Biologics Inc. Anti-ox40l antibodies and methods of use
WO2025233445A1 (en) * 2024-05-08 2025-11-13 Kymab Limited Treatment of head and neck atopic dermatitis
WO2025255353A1 (en) * 2024-06-06 2025-12-11 Apogee Therapeutics, Inc. Dosage and administration of an anti-ox40l antibody

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7812133B2 (en) * 2005-12-16 2010-10-12 Genentech, Inc Anti-OX40L antibodies and methods using same
US7608693B2 (en) 2006-10-02 2009-10-27 Regeneron Pharmaceuticals, Inc. High affinity human antibodies to human IL-4 receptor
EP3309176B1 (en) * 2009-12-14 2025-10-01 Ablynx N.V. Immunoglobulin single variable domain antibodies against ox40l, constructs and their therapeutic use
GB201403775D0 (en) * 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
AU2015301338C1 (en) * 2014-08-04 2021-07-22 Baylor Research Institute Antagonistic anti-OX40L antibodies and methods of their use
KR20250005465A (ko) 2015-03-03 2025-01-09 키맵 리미티드 항체, 용도 및 방법
US9512229B2 (en) * 2015-03-03 2016-12-06 Kymab Limited Synergistic combinations of OX40L antibodies for the treatment of GVHD
EP3534947A1 (en) 2016-11-03 2019-09-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods

Similar Documents

Publication Publication Date Title
JP2024530954A5 (https=)
US20250082750A1 (en) Methods for treating atopic dermatitis by administering an il-4r antagonist
JP6306588B2 (ja) Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法
JP2025172841A5 (https=)
JP2022543612A5 (https=)
CN112153982A (zh) 用于通过施用il-4r抑制剂治疗特应性皮炎的方法
JP2023520676A5 (https=)
US20250352644A1 (en) Il-13 antibodies for the treatment of atopic dermatitis
JP2019521156A (ja) Ｉｌ−１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP6803229B2 (ja) ベンラリツマブによる喘息症状の改善方法
US20250042985A1 (en) Interleukin 5 binding protein dosage regimen for use in treating polyangiitis, hypereosinophilic syndrome, chronic rhinosinusitis with nasal polyps (crswnp), or chronic rhinosinusitis without nasal polyps (crssnp)
US20240043524A1 (en) Interleukin 5 binding protein dosage regimen
RU2024105814A (ru) Лечение атопического дерматита
Saco et al. Biologics in allergic disease
TW202500184A (zh) 治療潰瘍性結腸炎之方法
HK40076109B (en) Methods for treating or preventing asthma by administering an il-4r antagonist
WO2025214333A1 (zh) 抗tslp抗体治疗与tslp相关的炎症疾病的方法
KR20220110512A (ko) 인터류킨-17(il-17) 길항제를 사용하여 편평 태선을 치료하는 방법
WO2022136209A1 (en) Interleukin 5 binding protein dosage regimen
JP2019178153A (ja) Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法
TH2001001181A (th) วิธีการสำหรับการบำบัดโรคที่เกี่ยวข้องกับ-tnf
HK40006965B (en) Methods for treating or preventing asthma by administering an il-4r antagonist
HK1211605B (en) Methods for treating or preventing asthma by administering an il-4r antagonist